News

Simon Coveney TD, Minister for Foreign Affairs and Trade, today officially ended a new expansion at BioMarin Pharmaceutical Inc. in Shanbally, Co Cork. BioMarin has recently extended its site footprint to 20 acres as the company continues to experience a rise in the global demand for its therapies to treat rare genetic diseases that mostly affec...

Nine new drugs are still on hold for public patients (file picture) The Department of Health has told the HSE it believes the executive has money to fund new drugs this year, despite HSE claims that it cannot do so within its current budget. Nine new drugs, which have been found to be clinically effective and cost effective and which the HSE wan...

The amyloid plaques that characterize Alzheimer’s disease are surrounded by microglia, which are neurological cells that help govern how the brain responds to injury. Now, scientists at the University of Pennsylvania have discovered three genetic variants in microglia that may enhance the immune system’s ability to fight Alzheimer’s—and that may...

Science Foundation Ireland invested €184m in R&D last year Public and private spending on the area of research and development is around 1.7% of GNP at the moment The Minister responsible for research and development has expressed doubt about whether Ireland will reach its target of doubling spending on it by 2020. John Halligan said he was unsu...

What is Chronic Granulamatous Disease? CGD is a disease of the immune system. It is described as a primary immunodeficiencydisorder. “Primary” means it is not caused by some other disease or disorder.1 In people who have CGD, a type of white blood cell called a phagocyte is defective.2 These defective phagocytes cannot generate superoxide, leadi...

Write something here...

IRELAND SHOWCASING HORIZON 2020 SUCCESS AND INFLUENCING NEXT FRAMEWORK PROGRAMME IN BRUSSELS. Bill Morrissey, Glanbia Ingredients Ireland Limited; Professor Mark Ferguson, Director General, Science Foundation Ireland and Robert-Jan Smits, Director General, DG Research & Innovation, EC Voila- 4th July- Ireland’s enterprise and innovation agencies...

Bristol-Myers Squibb to sell Swords manufacturing facility SK Biotek, a South Korean company, will acquire the facility Fri, Jun 16, 2017, 15:47 Peter Hamilton Bristol-Myers Squibb intends to shift its manufacturing focus in Ireland to reflect its “growing biologics portfolio” SK Biotek, a South Korean biotechnology firm, has acquired an active ...

.